HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
Advancing Hypertension Management: Unmet Needs, Endothelial Dysfunction, and CKD Therapies
December 2nd 2024Manesh R. Patel, MD; Payal Kohli, MD, FACC; John M. Flack, MD, MPH, FAHA, FASH, MACP, CHS, and C. Michael Gibson, MS, MD, explore the challenges and evolving management strategies for resistant hypertension, including medication adherence, comorbidities like CKD, traditional and novel drug mechanisms like aprocitentan, and the importance of accurate blood pressure measurement, while emphasizing the critical role of the endothelin pathway and comprehensive treatment approaches.
Treatment of Familial Chylomicronemia Syndrome: A Multidisciplinary Approach
November 27th 2024Panelists discuss how a multidisciplinary approach, early diagnosis, and emerging therapies are essential in managing Familial Chylomicronemia Syndrome (FCS)to prevent acute pancreatitis and mitigate long-term cardiovascular risks.
From LDL-C to Lp(a): A Multispecialty Approach to Reducing the Rising Tide of Cardiovascular Disease
November 26th 2024Panelists discuss how comprehensive cardiovascular disease management requires integrating screening protocols, risk assessment, and targeted interventions across the lifespan, from pediatric lipid testing through adult treatment strategies, while addressing barriers to care and leveraging both established and emerging therapeutic options.
Enhancing CKD Care in Type 2 Diabetes: Bridging Gaps in Diagnosis, Treatment, and Patient Outcomes
November 7th 2024Panelists discuss how addressing the gaps in screening, diagnosis, and treatment can significantly improve outcomes for patients with chronic kidney disease (CKD) in the context of type 2 diabetes.
Expanding Treatment Options for Primary Biliary Cholangitis with Novel Therapies
November 7th 2024This discussion provides an in-depth overview of Primary Biliary Cholangitis (PBC), covering pathophysiology, clinical presentation, diagnostic approaches, disease progression, management strategies—including first- and second-line therapies—and recent advances in PPAR agonist treatments to guide optimal care for patients.
Peer Exchange: Evolving Perspectives and Treatment Strategies in Chronic Spontaneous Urticaria
October 21st 2024Panelists discuss how to effectively diagnose and manage chronic spontaneous urticaria, highlighting the importance of personalized treatment approaches and the exploration of emerging therapies to improve patient outcomes.
Evolving Perspectives and Treatment Strategies in Chronic Spontaneous Urticaria
October 18th 2024Panelists discuss how evolving treatment strategies and improved diagnostic approaches can enhance the management of Cchronic Sspontaneous Uurticaria (CSU), ultimately aiming to improve patient outcomes and quality of life.
Recent Advances in Treatment of Alopecia Areata
October 14th 2024Panelists discuss how early diagnosis and the utilization of systemic Janus kinase inhibitors are crucial in the effective management of alopecia areata, highlighting the impact of disease severity and patient experiences on treatment strategies.
Advances in Oral Systemic Treatments for Management of Atopic Dermatitis
September 4th 2024Raj Chovatiya, MD, PhD, MSCI; George Han, MD; Elizabeth (Lisa) Swanson, MD; and Peter Lio, MD, explore the latest advances in oral systemic treatments for atopic dermatitis, including the use and long-term safety of oral JAK inhibitors, strategies for switching therapies, and navigating treatment breaks.
Iron Deficiency Anemia Across Specialties: Optimizing Patient Outcomes through Collaborative Care
July 15th 2024A panel of experts on iron deficiency anemia has a comprehensive discussion on the clinical utilization of intravenous iron, highlighting available products and clinical practices on administration and monitoring.
Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach
May 14th 2024Experts on chronic obstructive pulmonary disease (COPD) have a comprehensive discussion on treatment practices, with a focus on emerging pathways and the role of type 2 inflammation in patients with the disease.
Simplifying HIV Treatment in the Presence of Drug Resistance; Preventing from the Start
May 8th 2024A panel of experts discuss simplified treatment approaches for HIV, highlighting the role of the primary care and advanced practice provider, the importance of early treatment initiation, and ways to manage drug resistance.
Identifying Hypercortisolism in Patients with Resistant Diabetes
April 8th 2024Hanford Yau, MD, Ralph DeFronzo, MD, Pam Kushner, MD, Honey East, MD, and Christopher Lucci, MD, discuss the challenges of managing patients with resistant diabetes, emphasizing key strategies for identifying and treatingunderlying hypercortisolismthat leads to resistant diabetes.
Optimizing Outcomes When Using Biologics for Treatment of Psoriasis
March 29th 2024Experts extensively review the array of psoriasis treatments, from topicals to biologics, exploring the landscape of IL therapies and their enhanced safety and efficacy compared to previous agents. The physicians also highlight how common comorbidities may impact on treatment decisions.
Transforming Retinal Disease Management with Novel Therapies
March 21st 2024A panel of ophthalmologists and vitreoretinal specialists discuss treatments for retinal diseases, specifically neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Experts highlight two new therapies, aflibercept 8 mg and faricimab, and how the addition of biosimilars and gene therapy are changing the landscape of care for the better.
Optimizing Treatment of Psoriasis in Patients with Skin of Color
March 7th 2024Leading dermatologists discuss management of psoriasis in patients with skin of color, including disease presentation, cultural stigma and its impact on patient’s quality of life. They also share recently presented and published data, highlighting use of biologics for treatment of psoriasis in patients with skin of color.
Dual-Orexin Receptor Antagonists for Treatment of Insomnia
December 21st 2023In an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.
JAK Inhibitors in the Evolving Treatment Landscape of Atopic Dermatitis
November 16th 2023Expert dermatologists discuss the use of Janus kinase (JAK) inhibitors for the treatment of atopic dermatitis (AD). They review the nuances of currently approved JAK inhibitors, share treatment considerations for AD, and discuss utilizing JAK inhibitors in clinical practice.
Curing your Patients from Hepatitis C: Addressing Complex Needs with Simplified Treatment Approaches
November 14th 2023A straight forward approach to taking care of patients with Hepatitis C. Experts in the field are offering a simplified overview for new providers on the who, what, where and when of hepatitis C care, as well as practical tips for treatment implementation
Addressing Patient Needs in Seborrheic Dermatitis with Novel Therapies
November 7th 2023Dermatologists discuss the burdens, unmet needs, and emerging treatment options for patients with seborrheic dermatitis, offering clinical insights on therapeutic approaches and the importance of patient-centered care.